WHO ICTRP trial
Molecular imaging before and during (chemo-) radiotherapy in patients with…
EUCTR2015-005278-40-NL · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2015-005278-40-NL |
|---|---|
| Public title | Molecular imaging before and during (chemo-) radiotherapy in patients with locally advanced Head and Neck, thoracic and pelvic tumors: prognostic and predictive value of 18F-fluoroazomycin arabinoside-PET/CT in head and neck squamous cell carcinoma. |
| Scientific title | Molecular imaging before and during (chemo-) radiotherapy in patients with locally advanced Head and Neck, thoracic and pelvic tumors: prognostic and predictive value of 18F-fluoroazomycin arabinoside-PET/CT in head and neck squamous cell carcinoma. |
| Primary sponsor | Radboudumc |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): yes Therapeutic use (Phase IV): no |
| Countries | Netherlands |
| Conditions | Head and neck squamous cell carcinoma (HNSCC) MedDRA version: 19.0 Level: PT Classification code 10060121 Term: Squamous cell carcinoma of head and neck System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts… |
| Interventions | Product Name: [18F]-FAZA Pharmaceutical Form: Radiopharmaceutical precursor, solution INN or Proposed INN: [18F]-fluoroazomycin arabinoside Other descriptive name: [18F]-FAZA Concentration unit: MBq/ml megabecquerel(s)/millilitre… |
| Registration date | Sep 5, 2016 |
| Target size | 60 |
| Secondary IDs | ABR-55752 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: